NantOmics has 6 close competitors: Atomwise, Ecovativa Design, Halda Therapeutics.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
NantOmicsAtomwiseEcovativa DesignFormation BioInsitroNantOmics develops molecular diagnostic and genomic sequencing products for personalized cancer treatment, part of Patrick Soon-Shiong's NantWorks network.
NantOmics competes with 6 companies here: Atomwise, Ecovativa Design, Halda Therapeutics, Formation Bio, Insitro, Retro Biosciences.
NantOmics was last valued at $100M (May 2022). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
No. NantOmics is a private company; its shares do not trade on a public exchange.
The last valuation is $100M.
Lead investors for each round are in the funding timeline.
The closest biotechnology / molecular diagnostics peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
